Generate a tailored SOP for Dr. Saurabh Dahiya. Improve your application with a focused, well-structured draft.
Saurabh Dahiya is a cancer specialist who is board-certified in internal medicine, hematology, and medical oncology. He serves as Associate Professor of Medicine at Stanford University School of Medicine and is Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy. His research primarily focuses on advancing cellular immunotherapies for hematologic malignancies, including CAR T-cell platforms and next-generation multiantigen targeting strategies for lymphoma. Dahiya leads multiple investigator-initiated and industry-sponsored trials in cellular immunotherapy aimed at translating correlative research insights to improve patient outcomes. He has authored over 100 peer-reviewed publications in prestigious journals such as the New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Blood, and Blood Advances. Prior to joining Stanford, he was faculty at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he contributed to the development of the Cellular Immunotherapy Program.